Who Paid My Doc
Richard Burwick
Maternal & Fetal Medicine West Covina, CA Medical Doctor
NPI 1740471531 CMS profile 1039511
1135 S Sunset Ave Ste 208, West Covina, CA 91790
General payments
$273,970
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$41,482
Through program year 2025, Richard Burwick of West Covina, CA is reported in the CMS Open Payments database as having received $273,970 across 265 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $41,482 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Maternal & Fetal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $21,071 | 18 | |
| 2024 | General | $51,977 | 40 | |
| 2023 | General | $62,539 | 42 | |
| 2022 | General | $50,523 | 48 | |
| 2021 | General | $10,880 | 11 | |
| 2020 | General | $10,874 | 13 | |
| 2019 | General | $66,107 | 93 |
Beside peers
- Richard Burwick
- Maternal & Fetal Medicine median
- Middle half of Maternal & Fetal Medicine
- National median
In program year 2025, general payments to Richard Burwick were reported at $21,071. Among 891 Maternal & Fetal Medicine profiles paid that year, the median was $56 and the middle half received between $25 and $146.
Show as a table
| Year | Richard Burwick | Maternal & Fetal Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $66,107 | $70 | $23–$148 | $163 |
| 2020 | $10,874 | $51 | $18–$141 | $114 |
| 2021 | $10,880 | $43 | $20–$137 | $132 |
| 2022 | $50,523 | $48 | $22–$145 | $149 |
| 2023 | $62,539 | $53 | $24–$150 | $160 |
| 2024 | $51,977 | $68 | $25–$159 | $164 |
| 2025 | $21,071 | $56 | $25–$146 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
265 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Maternal & Fetal Medicine in California
Shahram Daneshmand
Maternal & Fetal Medicine · San Diego, CA
Greggory Devore
Maternal & Fetal Medicine · Pasadena, CA
Neil Silverman
Maternal & Fetal Medicine · Los Angeles, CA
David Lagrew
Maternal & Fetal Medicine · Laguna Hills, CA
Chia-Ling Nhan-Chang
Maternal & Fetal Medicine · San Diego, CA
Lawrence Platt
Maternal & Fetal Medicine · Los Angeles, CA
Related records
Maternal & Fetal Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Maternal & Fetal Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.